Rheumatoid Arthritis and Risks of Malignant Lymphoma - Are Risks Still Increased?

被引：0
|
作者：
Hellgren, Karin [1 ]
Baecklund, Eva [2 ]
Smedby, Karin E. [3 ]
Backlin, Carin [4 ]
Sundstrom, Christer [5 ]
Askling, Johan [1 ,3 ]
机构：
[1] Rheumatol Unit, Stockholm, Sweden
[2] Rheumatol Unit, Uppsala, Sweden
[3] Clin Epidemiol Unit, Stockholm, Sweden
[4] Dept Med Sci, Uppsala, Sweden
[5] Dept Genet & Pathol, Uppsala, Sweden
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1229
引用
收藏
页码：S525 / S526
页数：2
相关论文
共 50 条
  • [31] Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis
    D'Andrea, Elvira
    Desai, Rishi J.
    He, Mengdong
    Glynn, Robert J.
    Lee, Hemin
    Weinblatt, Michael E.
    Kim, Seoyoung C.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (01) : 36 - 46
  • [32] Diabetes is associated with elevated risks of osteoarthritis, osteoporosis and rheumatoid arthritis
    Molsted, S.
    Bjorkman, A. -S. D.
    Andersen, M. B.
    Ekholm, O.
    [J]. DIABETOLOGIA, 2018, 61 : S543 - S544
  • [33] MALIGNANT-LYMPHOMA ASSOCIATED WITH RHEUMATOID-ARTHRITIS
    KATONGOLEMBIDDE, E
    OLWENY, CLM
    KANYEREZI, BR
    OWOR, R
    [J]. EAST AFRICAN MEDICAL JOURNAL, 1984, 61 (07) : 544 - 550
  • [34] Increased prevalence of coronary artery atherosclerosis in rheumatoid arthritis: Relationship with disease duration and cardiovascular risks factors.
    Chung, CP
    Oeser, A
    Paolo, RI
    Gebretsadik, T
    Shintani, A
    Pincus, T
    Sokka, T
    Avalos, I
    Stein, CM
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S554 - S554
  • [35] Malignant lymphomas in coeliac disease:: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma
    Smedby, KE
    Åkerman, M
    Hildebrand, H
    Glimelius, B
    Ekbom, A
    Askling, J
    [J]. GUT, 2005, 54 (01) : 54 - 59
  • [36] Facing nonscalability: are risks still 'risks' when compound and catastrophic?
    Fassert, Christine
    November, Valerie
    Rey-Thibault, Cassandre
    [J]. JOURNAL OF RISK RESEARCH, 2023, 26 (11) : 1157 - 1173
  • [37] Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations
    Mori, Shunsuke
    Sugimoto, Mineharu
    [J]. CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2015, 9 : 29 - 40
  • [38] Balancing the benefits and risks of low-dose glucocorticoid in rheumatoid arthritis
    Santiago, T.
    Jacobs, J. W.
    Saag, K. G.
    Buttgereit, F.
    Pereira da Silva, J. A.
    [J]. ACTA REUMATOLOGICA PORTUGUESA, 2015, 40 (01): : 10 - 22
  • [39] HLA-DR GENOTYPE RISKS IN SEROPOSITIVE RHEUMATOID-ARTHRITIS
    LEGRAND, L
    LATHROP, GM
    MARCELLIBARGE, A
    DRYLL, A
    BARDIN, T
    DEBEYRE, N
    POIRIER, JC
    SCHMID, M
    RYCKEWAERT, A
    DAUSSET, J
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1984, 36 (03) : 690 - 699
  • [40] METHOTREXATE IN JUVENILE RHEUMATOID-ARTHRITIS - DO THE BENEFITS OUTWEIGH THE RISKS
    GIANNINI, EH
    CASSIDY, JT
    [J]. DRUG SAFETY, 1993, 9 (05) : 325 - 339
12345